Cholinesterase Inhibitor [EPC]

Cholinesterase Inhibitor [EPC] was reported 19111 times

These side effects are most commonly reported by patients taking drugs of the Cholinesterase Inhibitor [EPC] class:

# Drug class Count
0 DEATH 2339
1 FALL 1793
2 HALLUCINATION 1482
3 CONFUSIONAL STATE 1331
4 DRUG INEFFECTIVE 980
5 VOMITING 922
6 NAUSEA 873
7 DIZZINESS 821
8 GAIT DISTURBANCE 753
9 PNEUMONIA 729
10 SOMNOLENCE 694
11 FATIGUE 686
12 MALAISE 681
13 DIARRHOEA 670
14 CONDITION AGGRAVATED 656
15 URINARY TRACT INFECTION 653
16 ASTHENIA 644
17 TREMOR 610
18 PARKINSON^S DISEASE 602
19 WEIGHT DECREASED 602
20 MEMORY IMPAIRMENT 599
21 GENERAL PHYSICAL HEALTH DETERIORATION 580
22 OFF LABEL USE 580
23 DEMENTIA 578
24 AGITATION 553
25 AGGRESSION 534
26 DECREASED APPETITE 512
27 COGNITIVE DISORDER 476
28 INSOMNIA 468
29 CEREBROVASCULAR ACCIDENT 456
30 DYSKINESIA 456
31 DYSPHAGIA 450
32 DYSPNOEA 426
33 HYPOTENSION 414
34 HALLUCINATION, VISUAL 413
35 ANXIETY 408
36 CONSTIPATION 405
37 DRUG INTERACTION 404
38 SYNCOPE 402
39 ON AND OFF PHENOMENON 381
40 ABNORMAL BEHAVIOUR 376
41 LOSS OF CONSCIOUSNESS 371
42 DEHYDRATION 369
43 SPEECH DISORDER 363
44 DISORIENTATION 355
45 MOBILITY DECREASED 352
46 BALANCE DISORDER 335
47 HYPERTENSION 324
48 DELIRIUM 322
49 DELUSION 316
50 DEMENTIA ALZHEIMER^S TYPE 315
51 FEELING ABNORMAL 315
52 PAIN 313
53 PYREXIA 311
54 HEADACHE 310
55 DEPRESSION 309
56 PRODUCT ADHESION ISSUE 299
57 MUSCLE RIGIDITY 295
58 BRADYCARDIA 281
59 RESTLESSNESS 281
60 APPLICATION SITE ERYTHEMA 277
61 PRODUCT DOSE OMISSION ISSUE 276
62 FREEZING PHENOMENON 257
63 PRURITUS 251
64 MUSCULOSKELETAL STIFFNESS 243
65 RASH 235
66 ABDOMINAL PAIN 233
67 ANAEMIA 224
68 BRADYKINESIA 221
69 CARDIAC ARREST 209
70 DEVICE ISSUE 209
71 HYPERHIDROSIS 209
72 ERYTHEMA 208
73 PRODUCT USE IN UNAPPROVED INDICATION 203
74 HIP FRACTURE 200
75 MUSCULAR WEAKNESS 200
76 APPLICATION SITE PRURITUS 197
77 MYOCARDIAL INFARCTION 196
78 BLOOD PRESSURE INCREASED 192
79 UNEVALUABLE EVENT 192
80 STOMA SITE DISCHARGE 191
81 PNEUMONIA ASPIRATION 189
82 PAIN IN EXTREMITY 184
83 HYPOPHAGIA 182
84 OEDEMA PERIPHERAL 180
85 APHASIA 173
86 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 171
87 DEVICE DISLOCATION 170
88 OVERDOSE 170
89 RENAL FAILURE 168
90 URINARY INCONTINENCE 168
91 AMNESIA 167
92 DISTURBANCE IN ATTENTION 166
93 SLEEP DISORDER 166
94 INFECTION 165
95 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 162
96 DEMENTIA ALZHEIMER'S TYPE 161
97 MUSCLE SPASMS 161
98 COUGH 159
99 PSYCHOTIC DISORDER 159
100 ACUTE KIDNEY INJURY 158
101 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 157
102 ORTHOSTATIC HYPOTENSION 156
103 SEIZURE 155
104 CARDIAC FAILURE 153
105 SEPSIS 153
106 ABNORMAL DREAMS 152
107 DRUG INTOLERANCE 151
108 PERIPHERAL SWELLING 151
109 HEAD INJURY 149
110 UNRESPONSIVE TO STIMULI 148
111 BLOOD PRESSURE DECREASED 147
112 ATRIAL FIBRILLATION 146
113 INCORRECT DOSE ADMINISTERED 146
114 STOMA SITE ERYTHEMA 146
115 ABDOMINAL PAIN UPPER 145
116 GAIT INABILITY 144
117 CARDIO-RESPIRATORY ARREST 143
118 GASTROINTESTINAL HAEMORRHAGE 142
119 PARANOIA 142
120 RESPIRATORY FAILURE 142
121 ABDOMINAL DISCOMFORT 141
122 DYSSTASIA 141
123 DEPRESSED LEVEL OF CONSCIOUSNESS 140
124 CHEST PAIN 139
125 ARTHRALGIA 137
126 FEMUR FRACTURE 135
127 BACK PAIN 134
128 CONVULSION 132
129 HYPERSENSITIVITY 132
130 ABASIA 131
131 COVID-19 131
132 HYPERSOMNIA 131
133 LETHARGY 131
134 WEIGHT INCREASED 130
135 HYPOKINESIA 128
136 MOVEMENT DISORDER 128
137 PRODUCT USE ISSUE 128
138 TOXICITY TO VARIOUS AGENTS 126
139 ARRHYTHMIA 125
140 HYPONATRAEMIA 125
141 DISEASE PROGRESSION 124
142 PARKINSONISM 124
143 UNDERDOSE 124
144 URINARY RETENTION 124
145 DYSTONIA 123
146 HOSPITALISATION 120
147 CARDIAC DISORDER 119
148 HYPERKINESIA 119
149 NIGHTMARE 118
150 PULMONARY EMBOLISM 117
151 DYSARTHRIA 112
152 GASTROINTESTINAL DISORDER 112
153 DEPRESSED MOOD 108
154 DIABETES MELLITUS 108
155 TRANSIENT ISCHAEMIC ATTACK 108
156 APPLICATION SITE RASH 106
157 ABDOMINAL DISTENSION 104
158 CONTUSION 103
159 HAEMOGLOBIN DECREASED 102
160 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 102
161 PSYCHOMOTOR HYPERACTIVITY 101
162 WRONG TECHNIQUE IN DRUG USAGE PROCESS 100
163 EATING DISORDER 99
164 CEREBRAL HAEMORRHAGE 98
165 MEDICATION ERROR 98
166 SALIVARY HYPERSECRETION 98
167 COMA 96
168 ADVERSE DRUG REACTION 94
169 DEVICE OCCLUSION 94
170 NERVOUSNESS 93
171 NASOPHARYNGITIS 92
172 WHITE BLOOD CELL COUNT INCREASED 92
173 RECTAL HAEMORRHAGE 91
174 NO ADVERSE EVENT 90
175 SEDATION 88
176 EPILEPSY 87
177 IRRITABILITY 87
178 PALLOR 87
179 MENTAL DISORDER 85
180 BLOOD GLUCOSE INCREASED 83
181 ASPIRATION 82
182 CHOKING 82
183 ANGER 81
184 BEDRIDDEN 81
185 CARDIAC FAILURE CONGESTIVE 81
186 MOTOR DYSFUNCTION 81
187 PARAESTHESIA 81
188 STRESS 81
189 FEEDING DISORDER 80
190 TACHYCARDIA 80
191 BLOOD CREATININE INCREASED 79
192 C-REACTIVE PROTEIN INCREASED 79
193 RENAL FAILURE ACUTE 79
194 DYSPHONIA 78
195 HEART RATE DECREASED 77
196 SKIN IRRITATION 77
197 THROMBOCYTOPENIA 77
198 HAEMATEMESIS 76
199 VISUAL IMPAIRMENT 76
200 AKINESIA 75
201 MENTAL IMPAIRMENT 75
202 PANCREATITIS 75
203 PRODUCTIVE COUGH 75
204 FEAR 74
205 MIDDLE INSOMNIA 73
206 PRESCRIBED UNDERDOSE 73
207 BLOOD PRESSURE FLUCTUATION 72
208 CHILLS 72
209 NOCTURIA 72
210 BLISTER 71
211 DECUBITUS ULCER 71
212 HAEMORRHAGE 71
213 HALLUCINATION, AUDITORY 71
214 ILLNESS 71
215 JOINT SWELLING 71
216 RESPIRATORY ARREST 71
217 APATHY 70
218 DEMENTIA WITH LEWY BODIES 70
219 HYPOGLYCAEMIA 70
220 INFARCTION 70
221 INTERNATIONAL NORMALISED RATIO INCREASED 70
222 POLLAKIURIA 70
223 STOMA SITE PAIN 70
224 DYSPEPSIA 69
225 EXTRAPYRAMIDAL DISORDER 69
226 LUNG DISORDER 69
227 URTICARIA 69
228 ANTICHOLINERGIC SYNDROME 68
229 APPLICATION SITE IRRITATION 68
230 ASTHMA 68
231 CRYING 68
232 DRY MOUTH 68
233 HYPOAESTHESIA 68
234 PARKINSON'S DISEASE 68
235 ALTERED STATE OF CONSCIOUSNESS 66
236 DEVICE DIFFICULT TO USE 66
237 EPISTAXIS 66
238 INFLUENZA 66
239 MULTI-ORGAN FAILURE 66
240 POSTURE ABNORMAL 66
241 OSTEOARTHRITIS 65
242 APPLICATION SITE HYPERSENSITIVITY 64
243 INCONTINENCE 64
244 MENTAL STATUS CHANGES 64
245 NEUROLEPTIC MALIGNANT SYNDROME 64
246 POOR QUALITY SLEEP 64
247 TENSION 64
248 CATARACT 63
249 SINUS BRADYCARDIA 63
250 VERTIGO 63
251 ELECTROCARDIOGRAM QT PROLONGED 62
252 HALLUCINATIONS, MIXED 62
253 RIB FRACTURE 62
254 TERMINAL STATE 62
255 SCREAMING 61
256 SUICIDAL IDEATION 61
257 CYSTITIS 60
258 DRUG DOSE OMISSION 60
259 DRUG HYPERSENSITIVITY 60
260 HEART RATE INCREASED 60
261 OXYGEN SATURATION DECREASED 60
262 THERAPEUTIC PRODUCT EFFECT DECREASED 60
263 CEREBRAL INFARCTION 59
264 CIRCULATORY COLLAPSE 59
265 INCOHERENT 59
266 RHABDOMYOLYSIS 59
267 SEPTIC SHOCK 58
268 THERAPEUTIC PRODUCT EFFECT VARIABLE 58
269 HYPERKALAEMIA 57
270 NONSPECIFIC REACTION 57
271 PLEURAL EFFUSION 57
272 STOMA SITE REACTION 57
273 THROMBOSIS 57
274 FLUID INTAKE REDUCED 56
275 PULMONARY OEDEMA 56
276 BRONCHITIS 55
277 FIBROMA 55
278 RESPIRATORY TRACT INFECTION 55
279 CEREBRAL ATROPHY 54
280 FAECALOMA 54
281 MALNUTRITION 53
282 GASTRITIS 52
283 HAEMATOMA 52
284 RENAL IMPAIRMENT 51
285 STOMA SITE INFECTION 51
286 THERAPEUTIC RESPONSE UNEXPECTED 51
287 DRUG ADMINISTRATION ERROR 50
288 MIOSIS 50
289 SKIN DISCOLOURATION 50
290 SUBDURAL HAEMATOMA 50
291 ACCIDENTAL OVERDOSE 49
292 DROOLING 49
293 LOWER LIMB FRACTURE 49
294 PRODUCT ADMINISTRATION ERROR 49
295 RENAL DISORDER 49
296 FLATULENCE 48
297 HYPOKALAEMIA 48
298 ILL-DEFINED DISORDER 48
299 MOOD ALTERED 48
300 SWELLING 48
301 THERAPEUTIC RESPONSE SHORTENED 48
302 FEMORAL NECK FRACTURE 47
303 INFLAMMATION 47
304 INJURY 47
305 ACTIVITIES OF DAILY LIVING IMPAIRED 46
306 ANOREXIA 46
307 APPLICATION SITE PAIN 46
308 APPLICATION SITE REACTION 46
309 BLOOD CREATINE PHOSPHOKINASE INCREASED 46
310 ILEUS 46
311 PRODUCT SUBSTITUTION ISSUE 46
312 VISION BLURRED 46
313 WOUND 46
314 ANAL INCONTINENCE 45
315 COMMUNICATION DISORDER 45
316 DEVICE BREAKAGE 45
317 HAEMATOCHEZIA 45
318 NEOPLASM MALIGNANT 45
319 PRODUCT AVAILABILITY ISSUE 45
320 PRODUCT DOSE OMISSION 45
321 TREATMENT NONCOMPLIANCE 45
322 ABNORMAL FAECES 44
323 NECK PAIN 44
324 REHABILITATION THERAPY 44
325 STOMA SITE INFLAMMATION 44
326 BLOOD UREA INCREASED 43
327 DIZZINESS POSTURAL 43
328 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 43
329 DRY SKIN 43
330 GASTRIC ULCER 43
331 PALPITATIONS 43
332 REDUCED FACIAL EXPRESSION 43
333 SURGERY 43
334 ARTHRITIS 42
335 ASPARTATE AMINOTRANSFERASE INCREASED 42
336 ATRIOVENTRICULAR BLOCK 42
337 INTESTINAL OBSTRUCTION 42
338 LEUKOCYTOSIS 42
339 MOOD SWINGS 42
340 MYOCLONUS 42
341 PRESYNCOPE 42
342 PRODUCT SUPPLY ISSUE 42
343 SUBILEUS 42
344 THINKING ABNORMAL 42
345 BLOOD PRESSURE ABNORMAL 41
346 DEVICE LEAKAGE 41
347 DYSURIA 41
348 GASTRIC DISORDER 41
349 OSTEOPOROSIS 41
350 CHEST DISCOMFORT 40
351 CHRONIC KIDNEY DISEASE 40
352 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 40
353 DERMATITIS CONTACT 40
354 DISCOMFORT 40
355 HEART RATE IRREGULAR 40
356 INITIAL INSOMNIA 40
357 LACTIC ACIDOSIS 40
358 ACUTE MYOCARDIAL INFARCTION 39
359 ALANINE AMINOTRANSFERASE INCREASED 39
360 CHOLELITHIASIS 39
361 GASTROOESOPHAGEAL REFLUX DISEASE 39
362 RETCHING 39
363 BLOOD POTASSIUM DECREASED 38
364 DEEP VEIN THROMBOSIS 38
365 DYSCHEZIA 38
366 HOSPICE CARE 38
367 NERVOUS SYSTEM DISORDER 38
368 OEDEMA 38
369 PRODUCT QUALITY ISSUE 38
370 RHINORRHOEA 38
371 STOMA SITE HYPERGRANULATION 38
372 UPPER LIMB FRACTURE 38
373 COLD SWEAT 37
374 EMOTIONAL DISTRESS 37
375 HYPERGLYCAEMIA 37
376 HYPOACUSIS 37
377 PLATELET COUNT DECREASED 37
378 SKIN EXFOLIATION 37
379 APPLICATION SITE VESICLES 36
380 BLADDER DISORDER 36
381 CLAVICLE FRACTURE 36
382 CONCOMITANT DISEASE AGGRAVATED 36
383 LUNG INFECTION 36
384 MANIA 36
385 MELAENA 36
386 MUSCLE TWITCHING 36
387 OBSESSIVE-COMPULSIVE DISORDER 36
388 PARALYSIS 36
389 PRODUCT PRESCRIBING ERROR 36
390 BOWEL MOVEMENT IRREGULARITY 35
391 CATATONIA 35
392 DEAFNESS 35
393 EMBEDDED DEVICE 35
394 FAECES DISCOLOURED 35
395 HEMIPLEGIA 35
396 HYPOXIA 35
397 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 35
398 MYALGIA 35
399 NASAL CONGESTION 35
400 RESPIRATORY DISORDER 35
401 STOMA SITE IRRITATION 35
402 SWELLING FACE 35
403 WITHDRAWAL SYNDROME 35
404 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 35
405 BEHAVIOUR DISORDER 34
406 BLOOD PRESSURE SYSTOLIC INCREASED 34
407 CARDIOMEGALY 34
408 CELLULITIS 34
409 COORDINATION ABNORMAL 34
410 HEMIPARESIS 34
411 JOINT INJURY 34
412 AKATHISIA 33
413 BURNING SENSATION 33
414 CHROMATURIA 33
415 DEVICE KINK 33
416 EMOTIONAL DISORDER 33
417 GASTROINTESTINAL SOUNDS ABNORMAL 33
418 HYPERTENSIVE CRISIS 33
419 MULTIPLE ORGAN DYSFUNCTION SYNDROME 33
420 NEPHROLITHIASIS 33
421 STOMA SITE HAEMORRHAGE 33
422 WHEELCHAIR USER 33
423 ALOPECIA 32
424 CHOLINERGIC SYNDROME 32
425 DEVICE USE ERROR 32
426 DIVERTICULITIS 32
427 FRACTURE 32
428 GAMMA-GLUTAMYLTRANSFERASE INCREASED 32
429 LIMB DISCOMFORT 32
430 VITAMIN B12 DEFICIENCY 32
431 ABDOMINAL TENDERNESS 31
432 DEVICE ALARM ISSUE 31
433 DIPLOPIA 31
434 HAEMATOCRIT DECREASED 31
435 HAEMATURIA 31
436 HEAD DISCOMFORT 31
437 HEPATITIS 31
438 HYPOTONIA 31
439 NEUROPATHY PERIPHERAL 31
440 PEMPHIGOID 31
441 RASH ERYTHEMATOUS 31
442 SKIN REACTION 31
443 APPARENT DEATH 30
444 APPLICATION SITE SWELLING 30
445 BLOOD ALKALINE PHOSPHATASE INCREASED 30
446 BLOOD SODIUM DECREASED 30
447 BRADYPHRENIA 30
448 DEVICE CONNECTION ISSUE 30
449 ENCEPHALOPATHY 30
450 FLUID RETENTION 30
451 HYPERNATRAEMIA 30
452 INTENTIONAL OVERDOSE 30
453 LIMB INJURY 30
454 PARKINSON^S DISEASE PSYCHOSIS 30
455 PELVIC FRACTURE 30
456 RESPIRATORY DISTRESS 30
457 SOPOR 30
458 SPINAL FRACTURE 30
459 UPPER GASTROINTESTINAL HAEMORRHAGE 30
460 VASCULAR ENCEPHALOPATHY 30
461 WHEEZING 30
462 ADVERSE EVENT 29
463 AMYLOID RELATED IMAGING ABNORMALITY-OEDEMA/EFFUSION 29
464 APPETITE DISORDER 29
465 ATRIOVENTRICULAR BLOCK COMPLETE 29
466 BLOOD CHOLESTEROL INCREASED 29
467 EXTRA DOSE ADMINISTERED 29
468 FAECAL INCONTINENCE 29
469 GASTROENTERITIS 29
470 HAEMORRHAGIC STROKE 29
471 HEPATIC ENZYME INCREASED 29
472 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 29
473 PRODUCT RESIDUE PRESENT 29
474 RESTLESS LEGS SYNDROME 29
475 SUDDEN DEATH 29
476 THERAPY CESSATION 29
477 TINNITUS 29
478 WRIST FRACTURE 29
479 BODY HEIGHT DECREASED 28
480 DERMATITIS BULLOUS 28
481 ELECTROCARDIOGRAM ABNORMAL 28
482 HIATUS HERNIA 28
483 IMMOBILE 28
484 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 28
485 JAUNDICE 28
486 LEUKOPENIA 28
487 LIVER DISORDER 28
488 LOWER RESPIRATORY TRACT INFECTION 28
489 MIGRAINE 28
490 PERIPHERAL COLDNESS 28
491 RASH PRURITIC 28
492 SKIN LESION 28
493 WHITE BLOOD CELL COUNT DECREASED 28
494 ANGIOEDEMA 27
495 BLOOD CHOLINESTERASE DECREASED 27
496 CARDIOVASCULAR DISORDER 27
497 DEVICE USE ISSUE 27
498 FAECES HARD 27
499 FUNGAL INFECTION 27
500 HERPES ZOSTER 27
501 INFLUENZA LIKE ILLNESS 27
502 LOGORRHOEA 27
503 PRESCRIBED OVERDOSE 27
504 PRODUCT ADMINISTRATION INTERRUPTED 27
505 RASH MACULAR 27
506 SPUTUM INCREASED 27
507 THERAPY INTERRUPTED 27
508 WRONG PRODUCT ADMINISTERED 27
509 AMYLOID RELATED IMAGING ABNORMALITY-MICROHAEMORRHAGES AND HAEMOSIDERIN DEPOSITS 26
510 CYANOSIS 26
511 FACIAL BONES FRACTURE 26
512 IMPAIRED QUALITY OF LIFE 26
513 INTERSTITIAL LUNG DISEASE 26
514 ISCHAEMIC STROKE 26
515 NEUTROPENIA 26
516 PANIC REACTION 26
517 SENILE DEMENTIA 26
518 SKIN DISORDER 26
519 TEMPERATURE INTOLERANCE 26
520 THERAPY NON-RESPONDER 26
521 VIRAL INFECTION 26
522 ACUTE RESPIRATORY FAILURE 25
523 BRONCHOPNEUMONIA 25
524 CEREBRAL ISCHAEMIA 25
525 COMPLETED SUICIDE 25
526 JOINT WARMTH 25
527 PANCREATITIS ACUTE 25
528 PHOTOSENSITIVITY REACTION 25
529 PLEUROTHOTONUS 25
530 PROSTATE CANCER 25
531 RHINITIS ALLERGIC 25
532 SKIN LACERATION 25
533 UROSEPSIS 25
534 BLOOD SODIUM INCREASED 24
535 BREAST CANCER 24
536 CARDIAC PACEMAKER INSERTION 24
537 INFREQUENT BOWEL MOVEMENTS 24
538 NASAL POLYPS 24
539 NEUTROPHIL COUNT INCREASED 24
540 APHAGIA 23
541 BLINDNESS 23
542 CHOLESTASIS 23
543 DAYDREAMING 23
544 DECREASED ACTIVITY 23
545 ENTERAL NUTRITION 23
546 HIP SURGERY 23
547 HYPOTHERMIA 23
548 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 23
549 JOINT DISLOCATION 23
550 MUSCULOSKELETAL PAIN 23
551 PARKINSONIAN GAIT 23
552 SINUSITIS 23
553 STATUS EPILEPTICUS 23
554 TACHYPNOEA 23
555 THERAPEUTIC RESPONSE DECREASED 23
556 VENTRICULAR EXTRASYSTOLES 23
557 ARTHROPATHY 22
558 CACHEXIA 22
559 CLOSTRIDIUM DIFFICILE INFECTION 22
560 COGWHEEL RIGIDITY 22
561 DRUG PRESCRIBING ERROR 22
562 DUODENAL ULCER 22
563 ECZEMA 22
564 FEELING COLD 22
565 FINE MOTOR SKILL DYSFUNCTION 22
566 FLUSHING 22
567 GASTRIC HAEMORRHAGE 22
568 GENERAL PHYSICAL CONDITION ABNORMAL 22
569 HYPOTHYROIDISM 22
570 ILLUSION 22
571 LUNG NEOPLASM MALIGNANT 22
572 MITRAL VALVE INCOMPETENCE 22
573 ORAL PAIN 22
574 PANIC ATTACK 22
575 PARADOXICAL DRUG REACTION 22
576 SECRETION DISCHARGE 22
577 SENSORY DISTURBANCE 22
578 SLEEP APNOEA SYNDROME 22
579 STOMA SITE EXTRAVASATION 22
580 TOXIC SKIN ERUPTION 22
581 ULCER 22
582 UNINTENTIONAL MEDICAL DEVICE REMOVAL 22
583 APRAXIA 21
584 BLOOD URINE PRESENT 21
585 COLITIS 21
586 DERMATITIS ALLERGIC 21
587 GRAND MAL CONVULSION 21
588 IMPAIRED HEALING 21
589 INTENTIONAL PRODUCT MISUSE 21
590 KIDNEY INFECTION 21
591 METABOLIC ACIDOSIS 21
592 MUSCULOSKELETAL DISORDER 21
593 OROPHARYNGEAL PAIN 21
594 PANCREATIC CARCINOMA 21
595 PRODUCT DOSE OMISSION IN ERROR 21
596 SOMNAMBULISM 21
597 STOMA SITE DISCOMFORT 21
598 SUSPICIOUSNESS 21
599 TRANSAMINASES INCREASED 21
600 ANGINA PECTORIS 20
601 APPLICATION SITE DISCOLOURATION 20
602 ATRIOVENTRICULAR BLOCK SECOND DEGREE 20
603 BLOOD GLUCOSE DECREASED 20
604 BODY TEMPERATURE INCREASED 20
605 CORONARY ARTERY DISEASE 20
606 DEFAECATION URGENCY 20
607 EYE DISORDER 20
608 FEELING HOT 20
609 GASTROINTESTINAL INFECTION 20
610 HYPERSEXUALITY 20
611 INFUSION SITE ERYTHEMA 20
612 REBOUND EFFECT 20
613 SHOCK 20
614 TASTE DISORDER 20
615 UPPER RESPIRATORY TRACT INFECTION 20
616 VASCULAR DEMENTIA 20
617 ANOSMIA 19
618 DERMATITIS 19
619 ELECTROLYTE IMBALANCE 19
620 EYE MOVEMENT DISORDER 19
621 FAILURE TO THRIVE 19
622 FREQUENT BOWEL MOVEMENTS 19
623 HANGOVER 19
624 INTENTIONAL PRODUCT USE ISSUE 19
625 LACRIMATION INCREASED 19
626 LIVER FUNCTION TEST ABNORMAL 19
627 LYMPHOEDEMA 19
628 NOSOCOMIAL INFECTION 19
629 PANCYTOPENIA 19
630 RASH MACULO-PAPULAR 19
631 ROAD TRAFFIC ACCIDENT 19
632 SCRATCH 19
633 SKIN ABRASION 19
634 SUICIDE ATTEMPT 19
635 SWOLLEN TONGUE 19
636 TYPE 2 DIABETES MELLITUS 19
637 AGRANULOCYTOSIS 18
638 ARTERIOSCLEROSIS 18
639 BLOOD POTASSIUM INCREASED 18
640 BUNDLE BRANCH BLOCK LEFT 18
641 CEREBELLAR ATROPHY 18
642 CYTOLYTIC HEPATITIS 18
643 DIABETES MELLITUS INADEQUATE CONTROL 18
644 DRUG DEPENDENCE 18
645 DYSENTERY 18
646 DYSGRAPHIA 18
647 FOOT DEFORMITY 18
648 HIP ARTHROPLASTY 18
649 INFUSION RELATED REACTION 18
650 ISCHAEMIA 18
651 PRODUCT PHYSICAL ISSUE 18
652 RALES 18
653 RESTING TREMOR 18
654 SKIN HAEMORRHAGE 18
655 SLEEP TALKING 18
656 SOCIAL AVOIDANT BEHAVIOUR 18
657 STUPOR 18
658 TORTICOLLIS 18
659 ACCIDENT 17
660 ACCIDENTAL EXPOSURE 17
661 APNOEA 17
662 ATELECTASIS 17
663 AUTONOMIC NERVOUS SYSTEM IMBALANCE 17
664 BENIGN PROSTATIC HYPERPLASIA 17
665 BONE PAIN 17
666 BRAIN OEDEMA 17
667 COLON CANCER 17
668 CONCOMITANT DISEASE PROGRESSION 17
669 DRUG EFFECT DECREASED 17
670 DRUG EFFECT INCOMPLETE 17
671 DYSGEUSIA 17
672 FOOD REFUSAL 17
673 HAND FRACTURE 17
674 HERNIA 17
675 HOT FLUSH 17
676 HYDROCEPHALUS 17
677 HYPERCALCAEMIA 17
678 HYPERVENTILATION 17
679 LACERATION 17
680 MICTURITION URGENCY 17
681 NIGHT SWEATS 17
682 PETIT MAL EPILEPSY 17
683 PRODUCT USE COMPLAINT 17
684 PSYCHIATRIC SYMPTOM 17
685 PURPURA 17
686 QUALITY OF LIFE DECREASED 17
687 RASH GENERALISED 17
688 SEXUAL DYSFUNCTION 17
689 SKIN ULCER 17
690 SLUGGISHNESS 17
691 STOMA COMPLICATION 17
692 STOMATITIS 17
693 TORSADE DE POINTES 17
694 TREATMENT FAILURE 17
695 WOUND INFECTION 17
696 ASPIRATION BRONCHIAL 16
697 BODY TEMPERATURE DECREASED 16
698 CRANIOCEREBRAL INJURY 16
699 CREATININE RENAL CLEARANCE DECREASED 16
700 DEVICE PHYSICAL PROPERTY ISSUE 16
701 EMPHYSEMA 16
702 EOSINOPHILIA 16
703 EYELID FUNCTION DISORDER 16
704 GASTROINTESTINAL TUBE INSERTION 16
705 GENERALISED TONIC-CLONIC SEIZURE 16
706 GRIMACING 16
707 HUMERUS FRACTURE 16
708 HYPERTONIA 16
709 HYPORESPONSIVE TO STIMULI 16
710 INCORRECT DRUG ADMINISTRATION DURATION 16
711 INFUSION SITE INDURATION 16
712 INJECTION SITE PAIN 16
713 LANGUAGE DISORDER 16
714 MULTIPLE SCLEROSIS 16
715 OCULAR HYPERAEMIA 16
716 POISONING 16
717 POTENTIATING DRUG INTERACTION 16
718 PROSTATOMEGALY 16
719 PRURITUS GENERALISED 16
720 PSYCHOTIC SYMPTOM 16
721 RASH PAPULAR 16
722 REPETITIVE SPEECH 16
723 STEVENS-JOHNSON SYNDROME 16
724 THERAPEUTIC PRODUCT EFFECT DELAYED 16
725 VENTRICULAR TACHYCARDIA 16
726 WALKING AID USER 16
727 BACTERIAL INFECTION 15
728 CARDIOPULMONARY FAILURE 15
729 CEREBRAL HAEMATOMA 15
730 CLONUS 15
731 CLOSTRIDIUM DIFFICILE COLITIS 15
732 DRUG TOXICITY 15
733 GASTROSTOMY 15
734 GLAUCOMA 15
735 HAEMORRHAGE INTRACRANIAL 15
736 IMPAIRED SELF-CARE 15
737 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 15
738 INCREASED APPETITE 15
739 LOWER GASTROINTESTINAL HAEMORRHAGE 15
740 OESOPHAGITIS 15
741 PERSONALITY CHANGE 15
742 PSYCHOTIC BEHAVIOUR 15
743 RED BLOOD CELL COUNT DECREASED 15
744 SCAR 15
745 SCHIZOPHRENIA 15
746 SINUS TACHYCARDIA 15
747 STOMA SITE ODOUR 15
748 THROAT IRRITATION 15
749 ACCIDENTAL EXPOSURE TO PRODUCT 14
750 AGNOSIA 14
751 BLADDER CATHETERISATION 14
752 BLOOD IRON DECREASED 14
753 BUNDLE BRANCH BLOCK RIGHT 14
754 CARDIOMYOPATHY 14
755 DRUG WITHDRAWAL SYNDROME 14
756 EMBOLISM 14
757 EUTHANASIA 14
758 GALLBLADDER DISORDER 14
759 GASTROINTESTINAL MOTILITY DISORDER 14
760 HEPATIC CIRRHOSIS 14
761 IMPULSE-CONTROL DISORDER 14
762 INCORRECT ROUTE OF DRUG ADMINISTRATION 14
763 LABYRINTHITIS 14
764 LISTLESS 14
765 LIVING IN RESIDENTIAL INSTITUTION 14
766 LYMPHOCYTE COUNT DECREASED 14
767 MACULAR DEGENERATION 14
768 MINI MENTAL STATUS EXAMINATION ABNORMAL 14
769 MYELODYSPLASTIC SYNDROME 14
770 OSTEOPENIA 14
771 PARTIAL SEIZURES 14
772 PERSECUTORY DELUSION 14
773 SINUS ARREST 14
774 VARICOSE VEIN 14
775 WHITE BLOOD CELLS URINE POSITIVE 14
776 AFFECTIVE DISORDER 13
777 AGEUSIA 13
778 APPLICATION SITE INFLAMMATION 13
779 ATRIAL FLUTTER 13
780 BACK INJURY 13
781 BLOOD BILIRUBIN INCREASED 13
782 CARDIOGENIC SHOCK 13
783 CEREBRAL DISORDER 13
784 CORONAVIRUS INFECTION 13
785 DISEASE RECURRENCE 13
786 FACIAL PARALYSIS 13
787 FOOT FRACTURE 13
788 HALLUCINATION, TACTILE 13
789 HEPATIC FUNCTION ABNORMAL 13
790 HEPATOCELLULAR INJURY 13
791 HICCUPS 13
792 HYPERTHERMIA 13
793 IRON DEFICIENCY ANAEMIA 13
794 LIPASE INCREASED 13
795 MULTIPLE FRACTURES 13
796 MUSCLE ATROPHY 13
797 MYDRIASIS 13
798 PARESIS 13
799 SEROTONIN SYNDROME 13
800 SKIN BURNING SENSATION 13
801 SKIN CANCER 13
802 STAPHYLOCOCCAL INFECTION 13
803 URINE OUTPUT DECREASED 13
804 APPLICATION SITE DERMATITIS 12
805 ATAXIA 12
806 ATRIOVENTRICULAR BLOCK FIRST DEGREE 12
807 BACK DISORDER 12
808 BIPOLAR DISORDER 12
809 BLOOD ALBUMIN DECREASED 12
810 CONTRAINDICATED PRODUCT ADMINISTERED 12
811 CROHN^S DISEASE 12
812 DRUG LEVEL INCREASED 12
813 DRUG-INDUCED LIVER INJURY 12
814 DYSPNOEA EXERTIONAL 12
815 END STAGE RENAL DISEASE 12
816 ENURESIS 12
817 ERUCTATION 12
818 ESCHAR 12
819 ESCHERICHIA URINARY TRACT INFECTION 12
820 EYE PAIN 12
821 FEBRILE NEUTROPENIA 12
822 FOOD INTOLERANCE 12
823 GASTRIC CANCER 12
824 GASTRIC ULCER HAEMORRHAGE 12
825 HAEMOPTYSIS 12
826 HAEMORRHAGIC ANAEMIA 12
827 IMPAIRED GASTRIC EMPTYING 12
828 INCORRECT PRODUCT ADMINISTRATION DURATION 12
829 INFUSION SITE SWELLING 12
830 INTESTINAL HAEMORRHAGE 12
831 LIBIDO INCREASED 12
832 LOCALISED INFECTION 12
833 LUNG INFILTRATION 12
834 MASTICATION DISORDER 12
835 MUSCLE CONTRACTIONS INVOLUNTARY 12
836 MUSCLE CONTRACTURE 12
837 NEURALGIA 12
838 NODULE 12
839 OSTEOMYELITIS 12
840 OXYGEN SATURATION ABNORMAL 12
841 PALLIATIVE CARE 12
842 PERICARDIAL EFFUSION 12
843 PERITONITIS 12
844 POLYPECTOMY 12
845 PROSTATIC DISORDER 12
846 PULMONARY CONGESTION 12
847 RHEUMATOID ARTHRITIS 12
848 SLOW SPEECH 12
849 SPINAL COLUMN INJURY 12
850 TROPONIN INCREASED 12
851 UNDERWEIGHT 12
852 VISUAL ACUITY REDUCED 12
853 WOUND COMPLICATION 12
854 ACUTE PULMONARY OEDEMA 11
855 ANKLE FRACTURE 11
856 AORTIC ANEURYSM 11
857 APHTHOUS ULCER 11
858 APPLICATION SITE BURN 11
859 BLOOD CALCIUM INCREASED 11
860 BLOOD GLUCOSE FLUCTUATION 11
861 BLOOD LACTATE DEHYDROGENASE INCREASED 11
862 BLOOD PRESSURE INADEQUATELY CONTROLLED 11
863 BONE DISORDER 11
864 CATARACT OPERATION 11
865 CEREBRAL THROMBOSIS 11
866 CHOLECYSTITIS 11
867 COAGULOPATHY 11
868 COMPLICATION ASSOCIATED WITH DEVICE 11
869 COMPULSIONS 11
870 CONJUNCTIVITIS 11
871 DISINHIBITION 11
872 DRUG DISPENSING ERROR 11
873 DRUG ERUPTION 11
874 DRUG TOLERANCE 11
875 ERYSIPELAS 11
876 EUPHORIC MOOD 11
877 EXCORIATION 11
878 EXPIRED PRODUCT ADMINISTERED 11
879 EYE SWELLING 11
880 FACE OEDEMA 11
881 FEELING JITTERY 11
882 FRONTOTEMPORAL DEMENTIA 11
883 GASTROENTERITIS VIRAL 11
884 HAEMORRHOIDS 11
885 HAND DEFORMITY 11
886 HYPERLIPIDAEMIA 11
887 INCREASED BRONCHIAL SECRETION 11
888 INFUSION SITE INFECTION 11
889 INFUSION SITE PAIN 11
890 INFUSION SITE REACTION 11
891 INTENTIONAL DOSE OMISSION 11
892 INTENTIONAL UNDERDOSE 11
893 LABORATORY TEST ABNORMAL 11
894 LACK OF SPONTANEOUS SPEECH 11
895 MEDICAL DEVICE DISCOMFORT 11
896 MUSCLE DISORDER 11
897 MUSCULOSKELETAL CHEST PAIN 11
898 NEPHROGENIC ANAEMIA 11
899 PANIC DISORDER 11
900 PATIENT ELOPEMENT 11
901 PERONEAL NERVE PALSY 11
902 POLYMYALGIA RHEUMATICA 11
903 POLYNEUROPATHY 11
904 PROTHROMBIN TIME PROLONGED 11
905 PSYCHOMOTOR SKILLS IMPAIRED 11
906 REFUSAL OF TREATMENT BY PATIENT 11
907 SICK SINUS SYNDROME 11
908 SLEEP TERROR 11
909 SPINAL COMPRESSION FRACTURE 11
910 STARING 11
911 STOMA SITE INDURATION 11
912 THERAPY PARTIAL RESPONDER 11
913 TOBACCO INTERACTION 11
914 TOOTH FRACTURE 11
915 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 11
916 URINARY CASTS PRESENT 11
917 VITAMIN D DEFICIENCY 11
918 VOLVULUS 11
919 WEIGHT FLUCTUATION 11
920 ANAPHYLACTIC REACTION 10
921 ASPHYXIA 10
922 BASAL GANGLIA INFARCTION 10
923 BLADDER CANCER 10
924 CARDIAC MURMUR 10
925 COLITIS ULCERATIVE 10
926 DELUSIONAL DISORDER, UNSPECIFIED TYPE 10
927 DEVICE PLACEMENT ISSUE 10
928 DEVICE RELATED INFECTION 10
929 DIABETIC COMPLICATION 10
930 DRUG ABUSE 10
931 DRUG RESISTANCE 10
932 DYSPHEMIA 10
933 EOSINOPHIL COUNT INCREASED 10
934 GASTROINTESTINAL PAIN 10
935 GENERAL SYMPTOM 10
936 HEPATIC NEOPLASM MALIGNANT 10
937 HYPOALBUMINAEMIA 10
938 HYPOVOLAEMIA 10
939 IMPULSIVE BEHAVIOUR 10
940 INCORRECT DOSE ADMINISTERED BY DEVICE 10
941 INCORRECT DOSE ADMINISTERED BY PRODUCT 10
942 INCORRECT PRODUCT DOSAGE FORM ADMINISTERED 10
943 INFUSION SITE NODULE 10
944 INJECTION SITE BRUISING 10
945 INJECTION SITE HAEMORRHAGE 10
946 INTERNAL HAEMORRHAGE 10
947 JOINT RANGE OF MOTION DECREASED 10
948 LACUNAR INFARCTION 10
949 LOCAL SWELLING 10
950 MALIGNANT NEOPLASM PROGRESSION 10
951 MASS 10
952 MEDICAL DEVICE CHANGE 10
953 MEDICAL DEVICE SITE DRYNESS 10
954 MICTURITION DISORDER 10
955 MULTIPLE SCLEROSIS RELAPSE 10
956 MUSCLE TIGHTNESS 10
957 NEURODEGENERATIVE DISORDER 10
958 POST PROCEDURAL COMPLICATION 10
959 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 10
960 PRODUCT DISPENSING ERROR 10
961 PRODUCT PRESCRIBING ISSUE 10
962 PULMONARY FIBROSIS 10
963 PURULENT DISCHARGE 10
964 PYELONEPHRITIS 10
965 RENAL CYST 10
966 RENAL FAILURE CHRONIC 10
967 RENAL INJURY 10
968 RESPIRATORY RATE INCREASED 10
969 SCAB 10
970 SHOCK HAEMORRHAGIC 10
971 SLOW RESPONSE TO STIMULI 10
972 SPUTUM DISCOLOURED 10
973 SQUAMOUS CELL CARCINOMA 10
974 SUPRAVENTRICULAR EXTRASYSTOLES 10
975 SUSPECTED COVID-19 10
976 TARDIVE DYSKINESIA 10
977 THERMAL BURN 10
978 THROAT TIGHTNESS 10
979 TOOTH DISORDER 10
980 TOOTH LOSS 10
981 URINE ODOUR ABNORMAL 10
982 VAGINAL HAEMORRHAGE 10
983 WALKING DISABILITY 10
984 ACUTE CORONARY SYNDROME 9
985 ANAEMIA MACROCYTIC 9
986 ANEURYSM 9
987 APPLICATION SITE EXFOLIATION 9
988 ATROPHY 9
989 BASAL CELL CARCINOMA 9
990 BLINDNESS UNILATERAL 9
991 BLOOD TEST ABNORMAL 9
992 BONE DENSITY DECREASED 9
993 BRADYARRHYTHMIA 9
994 CARDIOACTIVE DRUG LEVEL INCREASED 9
995 CATHETER SITE ERYTHEMA 9
996 COMPUTERISED TOMOGRAM ABNORMAL 9
997 CONCUSSION 9
998 CORONARY ARTERY THROMBOSIS 9
999 DECREASED INTEREST 9